AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Alexander Volkov

Examiner Alexander Volkov appears to be about average relative to their peer examiners. Their lifetime grant ratio is 14.7%, they average 1.50 office actions per granted patent, and their rejection profile is dominated by §103 and occasional §101 rejections.

Difficulty vs AU About Average
Difficulty vs Group About Average
Difficulty vs TC About Average
Difficulty vs USPTO About Average
Average OA / Grant 1.50
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
5 years (2022-2026)
Phone
(571) 272-1899
Predicted Supervisor
N/A
Supervisor Phone
N/A
Tech Center
1600 - Biotechnology and Organic
Group
1670 - Virology and Related Immunology

Metrics

Applications Evaluated
109
Granted Applications
16
Non-Granted Applications
93
Avg OA / Grant
1.50
Last OA Observed
March 2026 (0 months ago)
Art Units Seen
1641 , 1677
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 14.7% 1.50
Art Unit 22 27.9% 2.22
Group 80 29.9% 1.92
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2022; examiner may not yet have been active in the available dataset.
2022 5 3 60.0%
2023 14 3 21.4%
2024 30 5 16.7%
2025 44 5 11.4%
2026 16 0 0.0%

16 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 95 4.2% 10.5% 53.7% 9.5%
2 63 3.2% 4.8% 76.2% 4.8%
3 43 7.0% 0.0% 65.1% 11.6%
4 31 0.0% 0.0% 80.6% 9.7%
5 15 0.0% 0.0% 73.3% 13.3%
6 10 0.0% 10.0% 70.0% 10.0%
7 5 0.0% 0.0% 80.0% 0.0%
8 2 0.0% 0.0% 100.0% 0.0%
10 1 0.0% 0.0% 100.0% 0.0%
11 1 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2022
5.7%
2023
3.6%
2024
1.2%
2025
6.3%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.